Core Viewpoint - The strategic partnership between Huajian Medical and Renhe Pharmaceutical aims to establish the world's first vertical RWA exchange focused on the OTC sector in the United States, marking a significant step in Huajian's ETHK blockchain financial ecosystem strategy [1][2] Group 1: Strategic Collaboration - The collaboration with Renhe Pharmaceutical represents a key milestone in the implementation of Huajian's ETHK blockchain financial ecosystem strategy and the innovative "ETHK global RWA exchange" business model [1] - This partnership is intended to create a replicable model that validates the feasibility and potential of the innovative approach [1] Group 2: Commitment to Economic Development - Huajian Medical emphasizes that the ultimate mission of financial technology is to serve the real economy and create inclusive value, which this collaboration exemplifies [2] - The company aims to leverage technology to assist classic national brands like Renhe Pharmaceutical in their digital transformation, promoting successful ecological models across various industries [2] Group 3: Future Growth and Synergy - The board believes that this collaboration will generate significant synergies, positively impacting the strategic transformation and value reassessment of both companies [2] - Huajian Medical plans to work closely with Renhe Pharmaceutical to ensure the successful launch and stable operation of the world's first OTC RWA exchange, aiming for high standards and quality [2]

Group 1 - The core viewpoint of the news is that Huajian Medical and Renhe Pharmaceutical have established a strategic partnership to create the world's first specialized trading platform for over-the-counter (OTC) real-world assets (RWA) [1][2] - The platform will adhere to securities-level standards and aims to provide an efficient, transparent, and compliant digital trading venue for intangible assets and product rights in the OTC industry, addressing a critical gap in the global market [1][2] - Renhe Pharmaceutical, as the president unit of the China OTC Association, plays a significant role in industry policy discussions and standard-setting, leveraging its competitive position in the Chinese OTC market to lead industry development [1] Group 2 - This strategic cooperation marks a new phase for the "ETHK" blockchain financial ecosystem strategy, showcasing the innovative "ETHK global RWA trading platform" model on a global stage [2] - The collaboration reflects the company's commitment to using cutting-edge technology and rigorous compliance practices to build an open and empowering digital financial ecosystem [2] - The partnership aims to facilitate the digital transformation of classic national brands like Renhe Pharmaceutical, contributing to national industrial upgrades and the development of the digital economy [2] Group 3 - The board believes that this collaboration will generate significant synergies, positively impacting the strategic transformation and value reassessment of both companies [3] - The companies will work closely to ensure the successful launch and stable operation of the world's first OTC RWA trading platform, leveraging their combined resources [3]

Core Viewpoint - The strategic partnership between Huajian Medical and Renhe Pharmaceutical aims to establish the world's first specialized trading platform for over-the-counter (OTC) real-world assets (RWA), addressing a significant gap in the global market [1][2]. Group 1: Strategic Collaboration - The collaboration signifies a new phase in Huajian Medical's "ETHK" blockchain financial ecosystem strategy, marking the global debut of its innovative "ETHK Global RWA Exchange" business model [2]. - Renhe Pharmaceutical, as the president unit of the China OTC Association, plays a crucial role in industry policy discussions and standard-setting, leveraging its strong market position to lead the development of the OTC sector [1][2]. Group 2: Goals and Vision - The partnership reflects the commitment to create a transparent, efficient, and compliant digital trading platform for intangible assets and product rights in the OTC industry, ultimately serving the broader goal of enhancing the digital economy and national industrial upgrades [2]. - The collaboration is expected to generate significant synergies, driving strategic transformation and value reassessment for both companies, while ensuring the successful launch and operation of the OTC RWA exchange [3].

Group 1 - The company has announced a strategic partnership with Renhe Pharmaceutical's wholly-owned subsidiary, Renhe International, to establish the world's first vertical RWA exchange focused on the OTC (over-the-counter) drug sector in the United States [1]

與 仁 和 藥 業（000650.SZ） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 IVD Medical Holding Limited 華檢醫療控股有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1931） 全資附屬公司仁和國際達成重大戰略合作 與 仁 和 藥 業（000650.SZ）間 接 全 資 附 屬 公 司 仁 和 國 際 達 成 重 大 戰 略 合 作，於 美 國 共 同 籌 建 全 球 首 家 非 處 方 藥（OTC）垂 直 領 域RWA交 易 所。 本 公 告 乃 由 華 檢 醫 療 控 股 有 限 公 司（「本公司」或「華檢醫療」，連 同 其 附 屬 公 司 統 稱「本集團」）自 願 作 出，旨 在 向 股 東 及 潛 在 投 資 者 提 供 本 集 團 業 務 發 展 的 最 新 資 料。 一、前 言：ETHK生態戰略的系統性深化 茲提述本公司日期為2025年 ...

华检医疗(01931)9月14日发布两则重磅公告：一是宣布与合作方ETHK Group达成协议，共同投资成立 两家新公司ETHK Inc及ETHK HOLDINGS LIMITED；二是建议将公司英文名称由"IVD Medical Holding Limited"更改为"ETHK Labs Inc."，中文双重外文名称由"华检医疗控股有限公司"更改为"华检数字产业 集团有限公司"。 华检医疗打造的ETHK生态志在成为中国资产链上出海的高速公路，为全球资本提供一站式投资优质资 产的平台。根据公告披露的信息，ETHK生态体系构建战略包含五大支柱： 坚实的技术基础设施：兼容并深度优化以太坊等主流公链生态，同时推进自主研发的高性能区块链底层 开发与部署。 丰富的金融产品与资产矩阵：全面布局货币市场基础资产、现实世界资产代币化(RWA)，重点推动包 括"链上股票"在内的股权资产代币化。 华检医疗9月14日，设立合资公司公告 这标志着华检医疗的业务重心正式转向数字产业技术基础设施的深度研发与全球输出，从一家医疗企业 转型为链上金融生态的构建者。华检医疗的"弃医从链"战略即刻引发市场激烈辩论：这是颠覆式创新的 开始，还是资 ...

"不谋全局者，不足谋一域；不谋万世者，不足谋一时。"在全球金融与科技深度交织的当下，资本市场 早已不是单一维度的竞技场，而是一个跨越边界、重塑秩序的超级舞台。谁能率先找到新的价值锚点， 谁就有机会在这场浪潮中掌握主动权。 9月14日，华检医疗(01931)的一纸公告，犹如平静湖面投入的一颗巨石，瞬间激起市场的涟漪与讨论。 公告显示，华检医疗将携手ETHK Group共同投资设立两家新公司：ETHK INC与ETHK HOLDINGS LIMITED，同时将公司英文名称由"IVD Medical Holding Limited"更名为"ETHK Labs Inc."，同时将中文 双重外文名称由"华检医疗控股有限公司"调整为"华检数字产业集团有限公司"。 华检医疗9月14日公告 乍看之下，这似乎只是一次常规的品牌升级与合资动作，但若拨开表层，便会发现这更像是一场跨越行 业与国界的价值重构。它释放的不仅是名称上的变化，更是医药产业与链上金融生态深度融合的信号; 它承载的不仅是企业战略的升级，更预示着中国优质资产"链上出海"的全新尝试。 问题是：华检医疗为何选择在此刻动作频频?这两家合资公司的设立，又将如何重塑全球价 ...

Core Viewpoint - The announcement by Huajian Medical on September 14 signifies a strategic shift towards integrating the pharmaceutical industry with blockchain finance, indicating a new attempt for Chinese quality assets to go global [1][5]. Group 1: Company Strategy - Huajian Medical is transitioning to focus on digital industries and blockchain finance to create new growth avenues and enhance long-term shareholder value [6]. - The rebranding to "ETHK Labs Inc." reflects the company's new positioning as a key technology and infrastructure provider within the ETHK blockchain financial ecosystem [6][11]. - The establishment of ETHK INC and ETHK HOLDINGS LIMITED aims to develop a decentralized financial platform and serve as an investment and acquisition hub for digital industries [7][11]. Group 2: Global Asset Tokenization - Huajian Medical's strategy includes exploring the tokenization of global assets, particularly focusing on the tokenization of equity assets, which allows for efficient and compliant global financing and value discovery [9]. - The initiative aims to convert research outcomes and intellectual property into tradable digital assets, broadening financing channels for companies [9]. Group 3: Compliance and Security - The joint venture emphasizes compliance and security, seeking relevant financial and payment licenses globally, and establishing a comprehensive compliance framework [10]. - The framework includes KYC, AML, and CFT procedures, along with risk management tools to ensure the secure circulation of innovative assets on the blockchain [10]. Group 4: Strategic Significance - The collaboration with ETHK Group represents a significant upgrade in Huajian Medical's strategy, aligning with the global trend of financial asset digitization and blockchain integration [11]. - This strategic layout provides a broader platform for quality assets and diverse investment opportunities while ensuring safety through a strict compliance framework [11]. Group 5: Future Considerations - The development of the blockchain financial ecosystem is still in its early stages, facing challenges in technology, regulation, and market perception [13]. - Key questions include how to overcome technical barriers, establish a unified regulatory framework, and enhance market participants' understanding of blockchain finance [13].

Core Viewpoint - Huajian Medical is undergoing a strategic transformation from a medical enterprise to a builder of a blockchain-based financial ecosystem, marking a significant shift in its business focus towards digital industry technology infrastructure [4][5]. Group 1: Strategic Transformation - The company has announced a partnership with ETHK Group to establish two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, focusing on decentralized financial platforms and digital industry investments [1][4]. - The rebranding reflects this shift, changing its English name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" [1][4]. - The new strategy aims to create a safe, efficient, compliant, and open decentralized financial platform under the "ETHK" brand [4]. Group 2: Global Asset Empowerment - The ETHK ecosystem is designed to facilitate the globalization of Chinese assets, providing a one-stop investment platform for global capital [6]. - The strategic framework includes five pillars: robust technical infrastructure, diverse financial products, sustainable business models, global compliance frameworks, and seamless user experiences [6]. - This approach addresses key pain points in the globalization of Chinese assets, such as limited financing channels and low cross-border flow efficiency [6]. Group 3: Financial Infrastructure for National Benefit - The strategic upgrade aligns with national policies promoting the marketization of intellectual property and innovation in technology finance [7]. - The ETHK strategy is positioned to enhance the international pricing power of Chinese assets and support the internationalization of the Renminbi [9]. - Market data indicates a significant growth potential in the tokenized asset market, with predictions of a global market size reaching $16.1 trillion by 2030 [7]. Group 4: Value Creation Paradigm - The new positioning reflects a thoughtful strategic choice, aiming to create value for various stakeholders, including the nation, industry, society, and investors [9]. - The ETHK ecosystem lowers the barriers for asset digitization, providing new financing avenues for high-tech enterprises and promoting inclusive finance [9]. - The company's stock performance has shown strong investor support, with shares rising from HKD 2 to HKD 10.44 since July, indicating confidence in the strategic direction [8].

Core Viewpoint - The announcement by Huajian Medical Holdings Limited regarding its partnership with ETHK Group marks a significant step towards creating a new financial ecosystem on the blockchain, aiming to facilitate the global flow and reconstruction of value, particularly in the Chinese healthcare sector [1][3]. Group 1: Company Overview - Huajian Medical is transitioning from a focus on in vitro diagnostics (IVD) to a broader role in the financial ecosystem by exploring the integration of assets and finance [7]. - The company is rebranding itself to reflect its new strategic direction, changing its name to Huajian Digital Industry Group Limited [1]. Group 2: Strategic Initiatives - The establishment of ETHK INC and ETHK HOLDINGS LIMITED is not merely a capital partnership but aims to build a decentralized and open financial platform [4]. - The ETHK ecosystem is built on five key pillars: technological infrastructure, financial products and asset matrix, sustainable business models, global compliance frameworks, and seamless user experience [5][6]. Group 3: Market Positioning - The collaboration is seen as a strategic extension that addresses the challenges of capital acceptance and value realization for innovative assets [7]. - The tokenization of assets is expected to enhance liquidity and provide a global platform for investment, breaking down geographical and institutional barriers [8][9]. Group 4: Industry Implications - The initiative is positioned as part of a broader trend towards the tokenization of real-world assets (RWA), which is gaining traction among major financial institutions [11]. - The ETHK ecosystem aims to serve as a public infrastructure for the global economy, emphasizing the importance of technology in rebuilding trust and facilitating cooperation [11]. Group 5: Future Outlook - The partnership represents a bold attempt to redefine the narrative of Chinese assets in the global capital landscape, with the potential to reshape financial order [14][15]. - The success of this venture could lead to significant changes in how value is discovered and exchanged on a global scale, particularly for Chinese innovative assets [13][15].